Rite Aid (RAD) Reports 1.5% Drop in May Comps
Tweet
Share
E-mailGet Alerts RAD Hot Sheet
Join SI Premium – FREE
Rite Aid (NYSE: RAD) announced sales results for May.
Monthly Sales
For the five weeks ended June 1, 2013, same store sales decreased 1.5 percent over the prior-year period. May front-end same store sales increased 0.8 percent. Pharmacy same store sales, which included an approximate 373 basis points negative impact from new generic introductions, decreased 2.7 percent. Prescription count at comparable stores decreased 0.3 percent over the prior-year period.
Total drugstore sales for the five-week period decreased 1.5 percent to $2.423 billion compared to $2.459 billion for the same period last year. Prescription sales accounted for 67.0 percent of drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended June 1, 2013 decreased 2.5 percent over the prior-year period. Front-end same store sales increased 0.4 percent while pharmacy same store sales decreased 3.8 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 13 weeks ended June 1, 2013 decreased 2.8 percent with sales of $6.264 billion compared to $6.441 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Monthly Sales
For the five weeks ended June 1, 2013, same store sales decreased 1.5 percent over the prior-year period. May front-end same store sales increased 0.8 percent. Pharmacy same store sales, which included an approximate 373 basis points negative impact from new generic introductions, decreased 2.7 percent. Prescription count at comparable stores decreased 0.3 percent over the prior-year period.
Total drugstore sales for the five-week period decreased 1.5 percent to $2.423 billion compared to $2.459 billion for the same period last year. Prescription sales accounted for 67.0 percent of drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended June 1, 2013 decreased 2.5 percent over the prior-year period. Front-end same store sales increased 0.4 percent while pharmacy same store sales decreased 3.8 percent. Prescription count at comparable stores decreased 0.1 percent over the prior-year period.
Total drugstore sales for the 13 weeks ended June 1, 2013 decreased 2.8 percent with sales of $6.264 billion compared to $6.441 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eldorado Gold names new board chair and lead independent director
- Anthropic's Ai Models Hacked Three Organizations During Tests
- Entegris Executive Chair Loy to retire, Gentilcore named board chair
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
